A detailed history of State Of Alaska, Department Of Revenue transactions in Incyte Corp stock. As of the latest transaction made, State Of Alaska, Department Of Revenue holds 34,059 shares of INCY stock, worth $2.62 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
34,059
Previous 53,389 36.21%
Holding current value
$2.62 Million
Previous $3.24 Million 30.47%
% of portfolio
0.02%
Previous 0.04%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$57.33 - $68.61 $1.11 Million - $1.33 Million
-19,330 Reduced 36.21%
34,059 $2.25 Million
Q2 2024

Aug 05, 2024

BUY
$51.18 - $63.75 $28,404 - $35,381
555 Added 1.05%
53,389 $3.24 Million
Q1 2024

Apr 19, 2024

SELL
$56.55 - $66.59 $583,878 - $687,541
-10,325 Reduced 16.35%
52,834 $3.01 Million
Q4 2023

Jan 19, 2024

SELL
$52.16 - $64.19 $59,983 - $73,818
-1,150 Reduced 1.79%
63,159 $3.97 Million
Q3 2023

Oct 16, 2023

BUY
$57.77 - $65.93 $444,540 - $507,331
7,695 Added 13.59%
64,309 $3.71 Million
Q2 2023

Jul 24, 2023

BUY
$60.95 - $75.51 $649,666 - $804,861
10,659 Added 23.19%
56,614 $3.52 Million
Q1 2023

Apr 17, 2023

SELL
$70.23 - $86.01 $5,548 - $6,794
-79 Reduced 0.17%
45,955 $3.32 Million
Q4 2022

Jan 11, 2023

BUY
$67.18 - $84.11 $425,249 - $532,416
6,330 Added 15.94%
46,034 $3.7 Million
Q3 2022

Oct 20, 2022

SELL
$66.18 - $82.86 $238,248 - $298,296
-3,600 Reduced 8.31%
39,704 $2.64 Million
Q2 2022

Jul 08, 2022

BUY
$66.18 - $83.18 $1.12 Million - $1.4 Million
16,860 Added 63.76%
43,304 $3.29 Million
Q1 2022

Apr 14, 2022

SELL
$66.02 - $79.71 $48,524 - $58,586
-735 Reduced 2.7%
26,444 $2.1 Million
Q4 2021

Jan 12, 2022

SELL
$63.34 - $74.11 $103,244 - $120,799
-1,630 Reduced 5.66%
27,179 $1.99 Million
Q3 2021

Oct 07, 2021

SELL
$68.67 - $84.02 $15,244 - $18,652
-222 Reduced 0.76%
28,809 $1.98 Million
Q2 2021

Jul 12, 2021

SELL
$79.87 - $87.53 $19,088 - $20,919
-239 Reduced 0.82%
29,031 $2.44 Million
Q1 2021

Apr 09, 2021

SELL
$76.02 - $100.5 $72,903 - $96,379
-959 Reduced 3.17%
29,270 $2.38 Million
Q4 2020

Jan 08, 2021

SELL
$80.74 - $97.7 $120,060 - $145,279
-1,487 Reduced 4.69%
30,229 $2.63 Million
Q3 2020

Oct 05, 2020

SELL
$85.07 - $109.69 $5.33 Million - $6.87 Million
-62,619 Reduced 66.38%
31,716 $2.85 Million
Q2 2020

Jul 06, 2020

BUY
$74.18 - $108.93 $4.72 Million - $6.93 Million
63,590 Added 206.83%
94,335 $9.81 Million
Q1 2020

Apr 06, 2020

BUY
$63.18 - $85.97 $85,861 - $116,833
1,359 Added 4.62%
30,745 $2.25 Million
Q4 2019

Jan 07, 2020

SELL
$73.04 - $95.72 $173,396 - $227,239
-2,374 Reduced 7.47%
29,386 $2.57 Million
Q3 2019

Oct 02, 2019

BUY
$72.82 - $86.52 $91,534 - $108,755
1,257 Added 4.12%
31,760 $2.36 Million
Q2 2019

Jul 23, 2019

BUY
$73.52 - $88.7 $74,108 - $89,409
1,008 Added 3.42%
30,503 $2.59 Million
Q1 2019

Apr 09, 2019

SELL
$63.56 - $88.17 $165,637 - $229,771
-2,606 Reduced 8.12%
29,495 $2.54 Million
Q4 2018

Jan 10, 2019

SELL
$58.5 - $69.94 $44,167 - $52,804
-755 Reduced 2.3%
32,101 $2.04 Million
Q3 2018

Oct 09, 2018

BUY
$61.75 - $74.23 $62,552 - $75,194
1,013 Added 3.18%
32,856 $2.27 Million
Q2 2018

Jul 10, 2018

BUY
$60.85 - $83.98 $486,191 - $671,000
7,990 Added 33.5%
31,843 $2.13 Million
Q1 2018

Apr 19, 2018

BUY
$83.06 - $100.98 $341,376 - $415,027
4,110 Added 20.82%
23,853 $1.99 Million
Q4 2017

Jan 19, 2018

BUY
$93.56 - $116.6 $1.06 Million - $1.32 Million
11,351 Added 135.26%
19,743 $1.87 Million
Q3 2017

Oct 16, 2017

BUY
$109.15 - $138.27 $915,986 - $1.16 Million
8,392
8,392 $979,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $17.1B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track State Of Alaska, Department Of Revenue Portfolio

Follow State Of Alaska, Department Of Revenue and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Alaska, Department Of Revenue, based on Form 13F filings with the SEC.

News

Stay updated on State Of Alaska, Department Of Revenue with notifications on news.